Trial Profile
Safety and effectiveness of rivaroxaban in anticoagulation therapy for elderly patients with atrial fibrillation and venous thromboembolism: a prospective observational study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Oct 2017
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Embolism and thrombosis
- Focus Adverse reactions
- 04 Oct 2017 New trial record